ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

WELLINGTON MANAGEMENT GROUP LLP's Holding History (CIK: 0000902219)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 129,876 Value ($000) $2,000 Avg Close $19.92 Range $15.14 - $24.64

Q3 2025

Shares 108,560 Value ($000) $2,222 Avg Close $20.16 Range $17.43 - $24.38

Q2 2025

Shares 94,012 Value ($000) $1,886 Avg Close $18.93 Range $13.30 - $24.11

Q1 2025

Shares 84,700 Value ($000) $1,667 Avg Close $21.52 Range $18.67 - $25.37

Q4 2024

Shares 80,916 Value ($000) $1,821 Avg Close $25.92 Range $21.43 - $30.03

Q3 2024

Shares 70,170 Value ($000) $1,792 Avg Close $23.16 Range $20.63 - $27.67

Q2 2024

Shares 33,903 Value ($000) $792 Avg Close $21.05 Range $15.96 - $26.00

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	129,876	$2,000	$19.92	$15.14 - $24.64
Q3 2025	108,560	$2,222	$20.16	$17.43 - $24.38
Q2 2025	94,012	$1,886	$18.93	$13.30 - $24.11
Q1 2025	84,700	$1,667	$21.52	$18.67 - $25.37
Q4 2024	80,916	$1,821	$25.92	$21.43 - $30.03
Q3 2024	70,170	$1,792	$23.16	$20.63 - $27.67
Q2 2024	33,903	$792	$21.05	$15.96 - $26.00